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Abstract
Aim: To establish the levels of docosahexaenoic acid
(DHA) and arachidonic acid (AA) in both plasma and
erythrocytes of maternal and cord blood as well as in
breast milk of mothers delivering babies at term.
Methods: A total of 148 mothers delivering babies at
term were recruited from Bharati Medical Hospital, Pune,
India.
Results: Levels of DHA and AA in both plasma and
erythrocyte were higher in cord blood compared to levels
in maternal blood (P-0.001). Maternal plasma and eryth-
rocyte DHA levels had a positive association with the
respective levels in cord blood (P-0.001). However, such
an association was not seen for AA levels. Maternal plas-
ma omega 3 and omega 6 fatty acids were positively
associated with the respective milk fatty acids (P-0.01).
Conclusions: Our results indicate that milk long-chain
polyunsaturated fatty acids (LCPUFA) status reflects the
concentrations of maternal LCPUFA in women delivering
babies at term. Improving the maternal LCPUFA status
throughout pregnancy and lactation may improve the
milk LCPUFA status and ultimately benefit the infant.
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Introduction
Long-chain polyunsaturated fatty acids (LCPUFA), espe-
cially docosahexaenoic acid (DHA) and arachidonic acid
(AA), are critical nutritional sources for the developing
fetus and infant w33x. DHA is the most vital LCPUFA for
visual and cognitive development w13, 19x and is known
to substantially accumulate in the brain during gestation
and in the postnatal period w6x. In mothers, AA and DHA
are synthesized to a limited extent, mainly in the liver by
desaturation and elongation of the essential fatty acids
linolenic and alpha-linolenic acid, respectively. Elongation
and desaturation enzymes for LCPUFA conversion are
present in the fetal liver early in gestation, but their activ-
ity appears to be low before birth w28x. Therefore, the
LCPUFA that the fetus accumulates in utero are derived
predominantly through placental transfer, which in turn,
is influenced by maternal diet and metabolism w21x. Stud-
ies suggest that infants cannot synthesize omega 3 and
omega 6 polyunsaturated fatty acids (PUFA) w19x. Human
milk provides the only source of n-6 and n-3 fatty acids
to support growth and development during breast-feed-
ing and for much of early infancy w16x. Hence, the infant
depends on breast milk for preformed LCPUFA in early
infancy which is also influenced by maternal diet. Thus,
this may compromise the maternal DHA status during
lactation.
Recent studies have shown that dietary DHA intake of
pregnant women between different communities is dif-
ferent w11, 23, 24, 30x. It has also been suggested that
further research into the ethnicity related differences in
maternal omega 3 and omega 6 fatty acid patterns may
be relevant to ethnic disparities in birth outcomes
observed worldwide w29x. Further, maternal dietary intake
of LCPUFA and lifestyle are known to influence the
LCPUFA levels of the fetus w1, 8x.
Fatty acid concentrations can be assessed from both
plasma and erythrocyte. It is known that fasting plasma
is suitable for assessing the steady state levels of both
LCPUFA following dietary intake of these and their pre-
cursors while erythrocyte fatty acids are indicative of
utilization of LCPUFA into generalized membrane phos-
pholipids. Also, the fatty acid composition of human milk
is known to be influenced by maternal nutritional status,
maternal dietary intakes immediately before and during
gestation, and the stage of lactation w5x.
Better understanding of the LCPUFA concentrations in
mother and in cord blood is of importance for improving
fetal DHA status not only in uncomplicated pregnancies
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but also in disorders associated with poor DHA status,
such as preeclampsia w26x. The present study describes
the levels of DHA and AA in plasma, erythrocyte and
breast milk simultaneously in Indian mothers who are
mostly vegetarians and delivering at term. These women
had a similar race, age, socio-economic status, diet and
life style which collectively minimize the confounders of
variability in fatty acids.
Materials and methods
The study was conducted at the Department of Obstetrics and
Gynecology, Bharati Medical College Hospital, Pune during the
period 2006–2007. Women with singleton pregnancies who
delivered at term a baby weighingG2.5 kg were recruited. Preg-
nant women with medical problems like chronic hypertension,
type 1 or type 2 diabetes mellitus, seizure disorder, alcohol or
drug abuse, were excluded from the study. Women who devel-
oped preeclampsia, gestational diabetes and anemia were also
excluded from the study. Delivery details and complications of
each subject were recorded.
Mode of delivery in all women was recorded: 80% of deliveries
were spontaneous vaginal, 12% were by cesarean section, 5%
were delivered by vacuum extraction and 3% were induced.
Birth outcome such as birth weight, height, head circumference
and chest circumference was recorded for all neonates by stan-
dard techniques within half an hour of birth.
Maternal samples and umbilical cord samples were collected
from each subject at the time of delivery but we had to omit a
few hemolytic samples. This study was approved by the Insti-
tutional Ethical Committee. Written informed consent was taken
from each subject. All women were of common racial origin and
had similar family lifestyle.
Dietary assessments
Food frequency questionnaire was used to estimate the fre-
quency of intake of omega three rich foods. These foods were
identified using ‘‘Nutritive Values of Indian Foods’’ w12x. The
questionnaire consisted of 17 food groups and a number of
foods (;10) were listed under each of the food groups. The
frequency of intake of foods was recorded on an 8-point scale
from ‘‘never’’ to ‘‘thrice daily’’. Thus, monthly scores were cal-
culated for each food item. For example, an item consumed
once a week will have a score of four while that consumed daily
will have a score of 30.
Sample collection, processing and storing
Maternal blood samples Ten milliliter of maternal venous
blood was collected into the ethylenediamine tetra-acetic acid
(EDTA) vials.
Cord blood samples Ten milliliter of blood was collected into
the EDTA vial from the umbilical cord just after delivery of the
neonate.
All blood samples were immediately layered on histopaque (a
density gradient obtained from Sigma-Aldrich) and centrifuged
at 2000 rpm for 30 min to separate the plasma and erythrocytes.
The erythrocytes were washed 3 times with normal saline. Then
the plasma and erythrocytes aliquots were stored at –808C until
further analysis.
Breast milk samples Breast milk was collected on a sub-sam-
ple. At the time of breast milk sampling, the babies were 3 days
of age. The mothers were instructed not to use skin care prod-
ucts before sampling. Breast milk samples (3 mL) were
taken in the middle of the baby’s being breast-fed and collected
in a 5 mL vial, stored at –808C, and analyzed within 10 days.
Fatty acid analysis Plasma and erythrocytes methyl esters
were prepared by the method of Manku et al. w25, 26x. Briefly,
transesterification of the phospholipid fraction was carried out
using hydrochloric acid-methanol. These were separated using
a Perkin Elmer gas chromatograph (SP 2330, 30 m capillary
Supelco column). Helium was used as carrier gas at 1 mL/min.
Oven temperature was held at 1508C for 10 min, programmed
to rise from 150 to 2208C at 108C/min, and at 2208C for 10 min.
The detector temperature was 2758C and the injector tempera-
ture was 2408C. Retention times and peak areas were automat-
ically computed. Peaks were identified by comparison with
standard fatty acid methyl esters (Sigma Aldrich, Inc. St. Louis,
USA). Fatty acids were expressed as g/100 g fatty acid. The total
omega 3 fatty acids included alpha linolenic acid, eicosapentae-
noic acid and DHA while total omega 6 fatty acids included lino-
lenic acid, gamma linolenic acid, di-homo-gamma linolenic acid,
docosapentaenoic acid and AA.
Statistical analysis Values were presented as mean"SD. The
data were analyzed using SPSS/PCq package (Version 11.0,
Chicago, IL). Skewed variables (maternal arachidonic acid and
docosahexaenoic acid in both plasma and erythrocyte, cord
plasma docosahexaenoic acid and breast milk docosahexaenoic
acid and arachidonic acid) were log transformed. Mean values
of the estimates of various parameters for maternal and cord
samples were compared using the Student t-test at conventional
levels of significance. Correlation between variables was studied
using Pearson’s correlation analysis.
Results
Table 1 shows the characteristics of the mothers and
neonates. All women consumed green leafy vegetables
which is mainly rich in alpha linolenic acid, a precursor
of DHA for about 4–5 times a week.
Table 2 shows the maternal (both plasma and eryth-
rocyte), cord (both plasma and erythrocyte) and breast
milk fatty acid composition. The maternal plasma omega
6/omega 3 fatty acid ratio was 20.5"7.9 whereas it was
7.33"2.38 in erythrocytes. Similarly, omega 6/omega 3
fatty acids ratio was 10.6"3.54 in cord plasma and
5.31"1.2 in erythrocytes.
Cord levels of both plasma and erythrocyte DHA and
AA were higher than the maternal blood levels
(P-0.001).
There was a positive weak association between mater-
nal plasma DHA and maternal erythrocyte DHA (ns121,
rs0.492, Ps0.001) and also between maternal plasma
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Table 1 Maternal and neonatal characteristics.
Maternal characteristics Mean"SD
(ns148)
Age (years) 22.5"3
Income per month ($) 89.2"48.8
Education (grade) 10"3
Total gestation (weeks) 39"0.9
Systolic blood pressure (mm Hg) 125.4"9.8
Diastolic blood pressure (mm Hg) 79.9"6.9
Pulse 83.2"6
Weight (kg) 50.4"7.6
Height (cm) 151.7"5.4
Gravida 1.7"1
Neonatal characteristics
Baby weight (kg) 2.9"0.3
Baby length (cm) 48.4"2.5
Head circumference (cm) 34.5"1.8
Chest circumference (cm) 32.6"1.4
Table 2 Maternal, cord and milk fatty acid levels (g/100 g fatty
acids).
Plasma Erythrocyte
(ns148) (ns121)
Mean"SD Mean"SD
Maternal fatty acids
AA w20:4 (n-6)x 6.3"2.1 13.4"2.4
DHA w22:6 (n-3)x 1.3"0.5 3.5"1
Total omega 3 2.1"0.7 3.9"1.1
Total omega 6 39.1"6 26.4"3.1
AA:DHA 5.1"1.8 4.2"1.4
Plasma Erythrocyte
(ns132) (ns117)
Cord fatty acids
AA w20:4 (n-6)x 13.6"3.9* 17.2"2*
DHA w22:6 (n-3)x 2.1"0.8* 4.2"0.9*
Total omega 3 2.9"0.9* 4.8"1*
Total omega 6 28.8"6.2* 24.2"2.5*
AA:DHA 7.2"2.7* 4.3"0.9
Breast milk
(ns89)
Fatty acids
AA w20:4 (n-6)x 1"0.5
DHA w22:6 (n-3)x 0.2"0.1
Total omega 3 1.2"0.4
Total omega 6 24"4.5
AA:DHA 5.3"3
AAsarachidonic acid, DHAsdocosahexaenoic acid.
*P-0.001.
AA and maternal erythrocyte AA (ns121, rs0.242,
Ps0.007) (Figure 1). This association was seen in cord
samples only for DHA (ns115, rs0.501, Ps0.001) but
not for AA.
There was also a weak positive association between
maternal plasma DHA and cord plasma DHA (ns105,
rs0.337, Ps0.001); maternal erythrocyte DHA and cord
erythrocyte DHA (ns84, rs0.290, Ps0.007) (Figure 2)
whereas this association was not seen for both plasma
and erythrocyte AA concentrations between mother and
cord.
Maternal plasma DHA and AA concentrations did not
show any associations with milk DHA and AA concentra-
tions. However, maternal plasma omega 3 fatty acids
were positively associated with milk omega 3 (ns81,
rs0.230, Ps0.039). Further, maternal plasma omega 6
fatty acids were also associated with milk omega 6 fatty
acids (ns81, rs0.280, Ps0.011) (Figure 3).
Discussion
We simultaneously examined LCPUFA status in plasma
as well as in erythrocytes of maternal and cord blood
along with breast milk samples in mothers of term babies
weighing G2.5 kg. Our results indicate 1) Plasma and
erythrocyte DHA and AA levels were higher in cord blood
as compared to maternal blood. 2) Maternal plasma DHA
and AA were positively associated with maternal eryth-
rocyte DHA and AA, respectively. 3) Maternal plasma and
erythrocyte DHA levels were associated with cord plasma
and erythrocyte DHA levels but no association was seen
with AA. 4) Maternal plasma omega 3 and omega 6 fatty
acids were positively associated with milk omega 3 and
omega 6 fatty acids, respectively.
Maternal erythrocyte DHA levels were similar and AA
was lower in our study than those reported in a UK
cohort w27x. However, both AA and DHA levels in our
cohort were almost twice lower than those reported in
the United States and European women w2, 32x. One of
the difficulties in defining optimal intake of omega 3 fatty
acids is the lack of information on biochemical markers
of omega 3 fatty acid status. Most studies estimate the
intakes of omega 3 fatty acids by food recall and food
frequency questionnaire using food composition tables
which are an indirect measure of omega 3 fatty acid
status w7x. Our results suggest that levels of LCPUFA vary
between different communities and may be dependent
on their intakes and lifestyle. Thus, our study could be
useful to understand the requirement of essential fatty
acids in Indian women delivering at term.
Further, our results showed that maternal plasma as
well as erythrocyte DHA and AA concentrations were
higher in cord as compared to maternal blood. This sug-
gests that large quantities of maternal DHA and AA are
diverted to the fetus since they are important for fetal
development. DHA was preferentially transferred from the
maternal to the fetal circulation compared to other PUFAs
w22x. This is consistent with numerous studies that
showed higher LCPUFA concentrations in fetal than in
maternal circulation w3, 14, 15x and suggests a prefer-
ential uptake of LCPUFA by the placenta.
Our results showed a positive association between
both plasma and erythrocyte maternal DHA and cord
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Figure 1 Maternal plasma docosahexaenoic acid (DHA) and arachidonic acid (AA) with maternal erythrocyte concentrations.
Figure 2 Associations between maternal docosahexaenoic acid (DHA) (plasma and erythrocytes) with cord concentrations.
Figure 3 Associations between omega 3 and omega 6 fatty acids in maternal plasma and milk.
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blood DHA. This association was not seen with AA (both
plasma and erythrocyte). Studies have shown that
because of limited fetal capacity to synthesize LCPUFA,
the fetus depends on LCPUFA transfer across the pla-
centa. Although molecular mechanisms of placental
LCPUFA uptake and transport are not fully understood,
it has been demonstrated that a preferential DHA transfer
exists, and is supported by our data. Thus, the placenta
plays a vital role for the selective channeling of DHA from
maternal diet and body stores to the fetus w9, 13x. Further
studies would help to understand the molecular mecha-
nisms of LCPUFA transport across the placenta and the
impact on pregnancy outcome and fetal development.
In our study, maternal plasma DHA or AA did not show
a direct association with milk DHA or AA. However, there
was a positive association between plasma omega 3
fatty acid concentrations with milk omega 3 fatty acid
concentrations. A similar trend was also seen in the case
of omega 6 fatty acid concentrations. This might indicate
that the mammary gland also plays a role in determining
the DHA status of milk. Thus, milk LCPUFA reflects the
concentrations of LCPUFA in maternal plasma which, in
turn, are dependent on maternal diet w17x and probably,
maternal and mammary gland activities of the desatur-
ases and elongases involved in converting dietary lino-
lenic acid and alpha linolenic acid to LCPUFA. A recent
study has reported that the combined consumption of AA
and omega 3 LCPUFA showed a positive correlation
between milk AA and DHA concentrations with their cor-
responding values in erythrocyte phospholipids w31x.
In our cohort, comprising mainly of consumers of a
vegetarian diet, the mean levels of milk DHA are 0.2 g/
100 g total fatty acids. This is consistent with 0.2–0.3
levels of DHA in milk from women in Canada, the USA,
Europe and Australia w16, 18x. In contrast, the DHA of
human colostrums was 0.6 g/100 g in Australian than in
European samples w10x. The levels of DHA in human milk
are known to vary widely within and among populations
and women consuming diets high in fish and other
marine animals often have )1 g DHA/100 g total fatty
acids in breast milk w16x. High contents of DHA and total
n-3 LCPUFA were observed in the colostrum of St.
Lucian women who consume abundant fish w10x. Human
milk contains DHA in varying amounts depending on
maternal diet w22x.
During pregnancy, maternal LCPUFA body stores more
than the actual diet, influence the LCPUFA status of
breast milk fatty acid composition w20x. A recent review
strongly supports the benefits of adding DHA and AA to
infant formula and also advises to continue the provision
of dietary sources of LCPUFA during the second 6
months of life w19x. Our results suggest that improved
maternal LCPUFA status would greatly improve the milk
LCPUFA status which ultimately would improve the
neurodevelopment of the infant. A recent study in central
Europe has shown that a dose of 200 mg/day DHA from
mid-pregnancy through lactation is appropriate to
improve the DHA status of mothers and infants w4x.
Our findings have important implications for the effects
of omega 3 fatty acid interventions in pregnancy and lac-
tation that support improved fetal growth, pregnancy out-
comes and postnatal development.
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